1887

Chapter 41 : , and

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

, and , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap41-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap41-2.gif

Abstract:

This chapter talks about various environmental organisms that include , , , , , , , , and spp. in water, soil, the rhizosphere, and in and on plants including fruits and vegetables. Members of these genera are widely recognized as phytopathogens. The species discussed in the chapter grow well on standard laboratory media such as 5% sheep blood and chocolate agars. Genotyping strategy provides robust, reproducible, and portable results and is quickly becoming the preferred method for investigating bacterial epidemiology, evolution, and population structure. Repetitive-sequence PCR using a BOX A1R primer and multilocus variable-number tandem repeat analysis have been developed for to exclude a clonal outbreak. Of the organisms discussed in the chapter, is the only one for which serologic tests have been used clinically to diagnose the infection. The indirect hemagglutination assay, although not available commercially, is the most widely used test. It is performed by using a prepared antigen from strains of sensitized to sheep cells and includes unsensitized cells as a control. This assay can be adapted to a microtiter plate test system. MIC broth microdilution and the Etest are the preferred methodologies for susceptibility testing. For multiresistant strains, consideration could be given to testing for synergy with double or triple combinations of antimicrobial agents in reference laboratories. It is important to note, however, that neither checkerboard MIC broth microdilution testing nor multiple combination bactericidal antibiotic testing is standardized at present.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41

Key Concept Ranking

Gram-Negative Bacilli
0.535887
Antimicrobial Susceptibility Testing
0.4468415
Restriction Fragment Length Polymorphism
0.4396897
Type III Secretion System
0.4255062
Infectious Diseases
0.41578114
0.535887
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

(a) Gram stain of in a blood culture; (b) Gram stain of from a colony on blood agar.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(a) B. pseudomallei colonies on MacConkey agar; (b) B. pseudomallei colonies on blood agar; (c) B. pseudomallei colonies on Ashdown medium agar.

Citation: LiPuma J, Currie B, Peacock S, Vandamme P. 2011. , and , p 692-713. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch41
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap41
1. Aaron, S. D.,, W. Ferris,, D. A. Henry,, D. P. Speert,, and N. E. Macdonald. 2000. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am. J. Respir. Crit. Care Med. 161: 1206 1212.
2. Agger, W. A.,, T. H. Cogbill,, H. Busch, Jr.,, J. Landercasper,, and S. M. Callister. 1986. Wounds caused by corn-harvesting machines: an unusual source of infection due to Gram-negative bacilli. Rev. Infect. Dis. 8: 927 931.
3. Agodi, A.,, M. Barchitta,, V. Giannino,, A. Collura,, T. Pensabene,, M. L. Garlaschi,, C. Pasquarella,, F. Luzzaro,, F. Sinatra,, E. Mahenthiralingam,, and S. Stefani. 2002. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J. Hosp. Infect. 50: 188 195.
4. Alexander, B. D.,, E. W. Petzold,, L. B. Reller,, S. M. Palmer,, R. D. Davis,, C. W. Woods,, and J. J. LiPuma. 2008. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am. J. Transplant. 8: 1025 1030.
5. Alfieri, N.,, K. Ramotar,, P. Armstrong,, M. E. Spornitz,, G. Ross,, J. Winnick,, and D. R. Cook. 1999. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing. Infect. Control Hosp. Epidemiol. 20: 553 556.
6. Amornchai, P.,, W. Chierakul,, V. Wuthiekanun,, Y. Mahakhunkijcharoen,, R. Phetsouvanh,, B. J. Currie,, P. N. Newton,, N. van Vinh Chau,, S. Wongratanacheewin,, N. P. Day,, and S. J. Peacock. 2007. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J. Clin. Microbiol. 45: 3774 3776.
7. Arda, B.,, S. Aydemir,, T. Yamazhan,, A. Hassan,, A. Tunger,, and D. Serter. 2003. Comamonas testosteroni meningitis in a patient with recurrent cholesteatoma. APMIS 111: 474 476.
8. Aris, R. M.,, J. C. Routh,, J. J. LiPuma,, D. G. Heath,, and P. H. Gilligan. 2001. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am. J. Respir. Crit. Care Med. 164: 2102 2106.
9. Arpi, M.,, M. A. Victor,, I. Mortensen,, A. Gottschau,, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS 104: 108 114.
10. Ashdown, L. R. 1987. Indirect haemagglutination test for melioidosis. Med. J. Aust. 147: 364 365.
11. Ashdown, L. R. 1992. Melioidosis and safety in the clinical laboratory. J. Hosp. Infect. 21: 301 306.
12. Athan, E.,, A. M. Allworth,, C. Engler,, I. Bastian,, and A. C. Cheng. 2005. Melioidosis in tsunami survivors. Emerg. Infect. Dis. 11: 1638 1639.
13. Balandreau, J.,, V. Viallard,, B. Cournoyer,, T. Coenye,, S. Laevens,, and P. Vandamme. 2001. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl. Environ. Microbiol. 67: 982 985.
14. Baldwin, A.,, E. Mahenthiralingam,, K. M. Thickett,, D. Honeybourne,, M. C. Maiden,, J. R. Govan,, D. P. Speert,, J. J. LiPuma,, P. Vandamme,, and C. G. Dowson. 2005. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J. Clin. Microbiol. 43: 4665 4673.
15. Barbaro, D. J.,, P. A. Mackowiak,, S. S. Barth,, and P. M. Southern, Jr. 1987. Pseudomonas testosteroni infections: eighteen recent cases and a review of the literature. Rev. Infect. Dis. 9: 124 129.
16. Barker, P. M.,, R. E. Wood,, and P. H. Gilligan. 1997. Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr. Pulmonol. 23: 123 125.
17. Bauernfeind, A.,, I. Schneider,, R. Jungwirth,, and C. Roller. 1999. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J. Clin. Microbiol. 37: 1335 1339.
18. Berriatua, E.,, I. Ziluaga,, C. Miguel-Virto,, P. Uribarren,, R. Juste,, S. Laevens,, P. Vandamme,, and J. R. Govan. 2001. Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J. Clin. Microbiol. 39: 990 994.
19. Blackburn, L.,, K. Brownlee,, S. Conway,, and M. Denton. 2004. Cepacia syndrome’ with Burkholderia multivorans, 9 years after initial colonization. J. Cyst. Fibros. 3: 133 134.
20. Boutros, N.,, N. Gonullu,, A. Casetta,, M. Guibert,, D. Ingrand,, and L. Lebrun. 2002. Ralstonia pickettii traced in blood culture bottles. J. Clin. Microbiol. 40: 2666 2667.
21. Brett, P. J.,, D. DeShazer,, and D. E. Woods. 1998. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48( Pt. 1): 317 320.
22. Brisse, S.,, S. Stefani,, J. Verhoef,, A. Van Belkum,, P. Vandamme,, and W. Goessens. 2002. Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J. Clin. Microbiol. 40: 1743 1748.
23. Brisse, S.,, C. M. Verduin,, D. Milatovic,, A. Fluit,, J. Verhoef,, S. Laevens,, P. Vandamme,, B. Tummler,, H. A. Verbrugh,, and A. van Belkum. 2000. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J. Clin. Microbiol. 38: 1876 1884.
24. Burbage, D. A.,, M. Sasser,, and R. D. Lumsden. 1982. A medium selective for Pseudomonas cepacia. Phytopathology 72: 706.
25. Burdge, D. R.,, M. A. Noble,, M. E. Campbell,, V. L. Krell,, and D. P. Speert. 1995. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20: 445 448.
26. Burns, J. L.,, J. Emerson,, J. R. Stapp,, D. L. Yim,, J. Krzewinski,, L. Louden,, B. W. Ramsey,, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27: 158 163.
27. Centers for Disease Control and Prevention. 2000. Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb. Mortal. Wkly. Rep. 49: 532535.
28. Chantratita, N.,, E. Meumann,, A. Thanwisai,, D. Limmathurotsakul,, V. Wuthiekanun,, S. Wannapasni,, S. Tumapa,, N. P. Day,, and S. J. Peacock. 2008. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J. Clin. Microbiol. 46: 568 573.
29. Chantratita, N.,, V. Wuthiekanun,, D. Limmathurotsakul,, A. Thanwisai,, W. Chantratita,, N. P. Day,, and S. J. Peacock. 2007. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 77: 814 817.
30. Chantratita, N.,, V. Wuthiekanun,, D. Limmathurotsakul,, M. Vesaratchavest,, A. Thanwisai,, P. Amornchai,, S. Tumapa,, E. J. Feil,, N. P. Day,, and S. J. Peacock. 2008. Genetic diversity and microevolution of Burkholderia pseudomallei in the environment. PLoS Negl. Trop. Dis. 2: e182.
31. Chaowagul, W.,, W. Chierakul,, A. J. Simpson,, J. M. Short,, K. Stepniewska,, B. Maharjan,, A. Rajchanuvong,, D. Busarawong,, D. Limmathurotsakul,, A. C. Cheng,, V. Wuthiekanun,, P. N. Newton,, N. J. White,, N. P. Day,, and S. J. Peacock. 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprimsulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob. Agents Chemother. 49: 4020 4025.
32. Chaowagul, W.,, Y. Suputtamongkul,, M. D. Smith,, and N. J. White. 1997. Oral fluoroquinolones for maintenance treatment of melioidosis. Trans. R. Soc. Trop. Med. Hyg. 91: 599 601.
33. Chaowagul, W.,, N. J. White,, D. A. Dance,, Y. Wattanagoon,, P. Naigowit,, T. M. Davis,, S. Looareesuwan,, and N. Pitakwatchara. 1989. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159: 890 899.
34. Chen, J. S.,, K. A. Witzmann,, T. Spilker,, R. J. Fink,, and J. J. LiPuma. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139: 643 649.
35. Chen, W. M.,, S. Laevens,, T. M. Lee,, T. Coenye,, P. De Vos,, M. Mergeay,, and P. Vandamme. 2001. Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient. Int. J. Syst. Evol. Microbiol. 51: 1729 1735.
36. Cheng, A. C.,, W. Chierakul,, W. Chaowagul,, P. Chetchotisakd,, D. Limmathurotsakul,, D. A. Dance,, S. J. Peacock,, and B. J. Currie. 2008. Consensus guidelines for dosing of amoxicillinclavulanate in melioidosis. Am. J. Trop. Med. Hyg. 78: 208 209.
37. Cheng, A. C.,, and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18: 383 416.
38. Cheng, A. C.,, D. A. Fisher,, N. M. Anstey,, D. P. Stephens,, S. P. Jacups,, and B. J. Currie. 2004. Outcomes of patients with melioidosis treated with meropenem. Antimicrob. Agents Chemother. 48: 1763 1765.
39. Cheng, A. C.,, D. Godoy,, M. Mayo,, D. Gal,, B. G. Spratt,, and B. J. Currie. 2004. Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J. Clin. Microbiol. 42: 5477 5483.
40. Cheng, A. C.,, D. Limmathurotsakul,, W. Chierakul,, N. Getchalarat,, V. Wuthiekanun,, D. P. Stephens,, N. P. Day,, N. J. White,, W. Chaowagul,, B. J. Currie,, and S. J. Peacock. 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin. Infect. Dis. 45: 308 314.
41. Cheng, A. C.,, M. O’Brien,, K. Freeman,, G. Lum,, and B. J. Currie. 2006. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am. J. Trop. Med. Hyg. 74: 330 334.
42. Cheng, A. C.,, S. J. Peacock,, D. Limmathurotsakul,, G. Wongsuvan,, W. Chierakul,, P. Amornchai,, N. Getchalarat,, W. Chaowagul,, N. J. White,, N. P. Day,, and V. Wuthiekanun. 2006. Prospective evaluation of a rapid immunochromogenic cassette test for the diagnosis of melioidosis in northeast Thailand. Trans. R. Soc. Trop. Med. Hyg. 100: 64 67.
43. Cheng, A. C.,, D. P. Stephens,, and B. J. Currie. 2007. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst. Rev., Issue 2, Art. no. CD004400. doi: 10.1002/14651858.CD004400.pub3.ed.
44. Cheng, A. C.,, V. Wuthiekanun,, D. Limmathurosakul,, G. Wongsuvan,, N. P. Day,, and S. J. Peacock. 2006. Role of selective and nonselective media for isolation of Burkholderia pseudomallei from throat swabs of patients with melioidosis. J. Clin. Microbiol. 44: 2316.
45. Chetoui, H.,, P. Melin,, M. J. Struelens,, E. Delhalle,, M. M. Nigo,, R. De Ryck,, and P. De Mol. 1997. Comparison of biotyping, ribotyping, and pulsed-field gel electrophoresis for investigation of a common-source outbreak of Burkholderia pickettii bacteremia. J. Clin. Microbiol. 35: 1398 1403.
46. Chi, C. Y.,, C. P. Fung,, W. W. Wong,, and C. Y. Liu. 2004. Brevundimonas bacteremia: two case reports and literature review. Scand. J. Infect. Dis. 36: 59 61.
47. Chierakul, W.,, S. Anunnatsiri,, J. M. Short,, B. Maharjan,, P. Mootsikapun,, A. J. Simpson,, D. Limmathurotsakul,, A. C. Cheng,, K. Stepniewska,, P. N. Newton,, W. Chaowagul,, N. J. White,, S. J. Peacock,, N. P. Day,, and P. Chetchotisakd. 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprimsulfamethoxazole for the treatment of severe melioidosis. Clin. Infect. Dis. 41: 1105 1113.
48. Chierakul, W.,, W. Winothai,, C. Wattanawaitunechai,, V. Wuthiekanun,, T. Rugtaengan,, J. Rattanalertnavee,, P. Jitpratoom,, W. Chaowagul,, P. Singhasivanon,, N. J. White,, N. P. Day,, and S. J. Peacock. 2005. Melioidosis in 6 tsunami survivors in southern Thailand. Clin. Infect. Dis. 41: 982 990.
49. Christenson, J. C.,, D. F. Welch,, G. Mukwaya,, M. J. Muszynski,, R. E. Weaver,, and D. J. Brenner. 1989. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J. Clin. Microbiol. 27: 270 273.
50. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informal Supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
51. Clode, F. E.,, L. A. Metherell,, and T. L. Pitt. 1999. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 160: 374 375.
52. Coenye, T.,, E. Falsen,, B. Hoste,, M. Ohlen,, J. Goris,, J. R. Govan,, M. Gillis,, and P. Vandamme. 2000. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int. 2. J. Syst. Evol. Microbiol. 50( Pt. 2): 887 899.
53. Coenye, T.,, E. Falsen,, M. Vancanneyt,, B. Hoste,, J. R. Govan,, K. Kersters,, and P. Vandamme. 1999. Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int. J. Syst. Bacteriol. 49: 405 413.
54. Coenye, T.,, J. Goris,, P. De Vos,, P. Vandamme,, and J. J. LiPuma. 2003. Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov. Int. J. Syst. Evol. Microbiol. 53: 1075 1080.
55. Coenye, T.,, J. Goris,, T. Spilker,, P. Vandamme,, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol. 40: 2062 2069.
56. Coenye, T.,, B. Holmes,, K. Kersters,, J. R. W. Govan,, and P. Vandamme. 1999. Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively. Int. J. Syst. Bacteriol. 49: 37 42.
57. Coenye, T.,, S. Laevens,, A. Willems,, M. Ohlen,, W. Hannant,, J. R. W. Govan,, M. Gillis,, E. Falsen,, and P. Vandamme. 2001. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int. J. Syst. Evol. Microbiol. 51: 1099 1107.
58. Coenye, T.,, and J. J. LiPuma. 2002. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 149: 77 88.
59. Coenye, T.,, and J. J. LiPuma. 2002. Use of the gyrB gene for the identification of Pandoraea species. FEMS Microbiol. Lett. 208: 15 19.
60. Coenye, T.,, L. Liu,, P. Vandamme,, and J. J. LiPuma. 2001. Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J. Clin. Microbiol. 39: 4452 4455.
61. Coenye, T.,, E. Mahenthiralingam,, D. Henry,, J. J. LiPuma,, S. Laevens,, M. Gillis,, D. P. Speert,, and P. Vandamme. 2001. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int. J. Syst. Evol. Microbiol. 51: 1481 1490.
62. Coenye, T.,, L. M. Schouls,, J. R. Govan,, K. Kersters,, and P. Vandamme. 1999. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int. J. Syst. Bacteriol. 49( Pt 4): 1657 1666.
63. Coenye, T.,, T. Spilker,, A. Martin,, and J. J. LiPuma. 2002. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J. Clin. Microbiol. 40: 3300 3307.
64. Coenye, T.,, T. Spilker,, R. Reik,, P. Vandamme,, and J. J. LiPuma. 2005. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J. Clin. Microbiol. 43: 3463 3466.
65. Coenye, T.,, T. Spilker,, A. Van Schoor,, J. J. LiPuma,, and P. Vandamme. 2004. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 59: 952 954.
66. Coenye, T.,, P. Vandamme,, J. R. Govan,, and J. J. LiPuma. 2001. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39: 3427 3436.
67. Coenye, T.,, P. Vandamme,, and J. J. LiPuma. 2002. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg. Infect. Dis. 8: 692 696.
68. Coenye, T.,, P. Vandamme,, and J. J. LiPuma. 2003. Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients. Int. J. Syst. Evol. Microbiol. 53: 1339 1342.
69. Coenye, T.,, E. Vanlaere,, E. Falsen,, and P. Vandamme. 2004. Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int. J. Syst. Evol. Microbiol. 54: 1235 1237.
70. Cooper, G. R.,, E. D. Staples,, K. A. Iczkowski,, and C. J. Clancy. 2005. Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc. Pathol. 14: 145 149.
71. Corey, M.,, and V. Farewell. 1996. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am. J. Epidemiol. 143: 1007 1017.
72. Craven, D. E.,, B. Moody,, M. G. Connolly,, N. R. Kollisch,, K. D. Stottmeier,, and W. R. McCabe. 1981. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N. Engl. J. Med. 305: 621 623.
73. Currie, B. J.,, D. A. Dance,, and A. C. Cheng. 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102( Suppl. 1): S1 S4.
74. Currie, B. J.,, D. A. Fisher,, D. M. Howard,, and J. N. Burrow. 2000. Neurological melioidosis. Acta Trop. 74: 145 151.
75. Currie, B. J.,, D. A. Fisher,, D. M. Howard,, J. N. Burrow,, D. Lo,, S. Selva-Nayagam,, N. M. Anstey,, S. E. Huffam,, P. L. Snelling,, P. J. Marks,, D. P. Stephens,, G. D. Lum,, S. P. Jacups,, and V. L. Krause. 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 31: 981 986.
76. Currie, B. J.,, D. Gal,, M. Mayo,, L. Ward,, D. Godoy,, B. G. Spratt,, and J. J. LiPuma. 2007. Using BOX-PCR to exclude a clonal outbreak of melioidosis, p. 68. BMC Infect. Dis. 7: 68.
77. Currie, B. J.,, A. Haslem,, T. Pearson,, H. Hornstra,, B. Leadem,, M. Mayo,, D. Gal,, L. Ward,, D. Godoy,, B. G. Spratt,, and P. Keim. 2009. Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis. Emerg. Infect. Dis. 15: 169 174.
78. Currie, B. J.,, and S. P. Jacups. 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg. Infect. Dis. 9: 1538 1542.
79. Currie, B. J.,, S. P. Jacups,, A. C. Cheng,, D. A. Fisher,, N. M. Anstey,, S. E. Huffam,, and V. L. Krause. 2004. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health 9: 1167 1174.
80. Cystic Fibrosis Foundation. 2008. Patient Registry 2008. Annual Data Report to the Center Directors. Cystic Fibrosis Foundation, Bethesda, MD.
81. Dance, D. A.,, M. D. Smith,, H. M. Aucken,, and T. L. Pitt. 1999. Imported melioidosis in England and Wales. Lancet 353: 208.
82. Dance, D. A.,, V. Wuthiekanun,, P. Naigowit,, and N. J. White. 1989. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J. Clin. Pathol. 42: 645 648.
83. Daneshvar, M. I.,, D. G. Hollis,, A. G. Steigerwalt,, A. M. Whitney,, L. Spangler,, M. P. Douglas,, J. G. Jordan,, J. P. MacGregor,, B. C. Hill,, F. C. Tenover,, D. J. Brenner,, and R. S. Weyant. 2001. Assignment of CDC weak oxidizergroup (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J. Clin. Microbiol. 39: 1819 1826.
84. da Silva Filho, L. V. F.,, A. F. Tateno,, L. de F. Velloso,, J. E. Levi,, S. Fernandes,, C. N. O. Bento,, J. C. Rodrigues,, and S. R. T. S. Ramos. 2004. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR. Pediatr. Pulmonol. 37: 537 547.
85. De Baere, T.,, S. Steyaert,, G. Wauters,, P. Des Vos,, J. Goris,, T. Coenye,, T. Suyama,, G. Verschraegen,, and M. Vaneechoutte. 2001. Classification of Ralstonia pickettii biovar 3/‘thomasii’ strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int. J. Syst. Evol. Microbiol. 51: 547 558.
86. De Boeck, K.,, A. Malfroot,, L. Van Schil,, P. Lebecque,, C. Knoop,, J. R. Govan,, C. Doherty,, S. Laevens,, and P. Vandamme. 2004. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur. Respir. J. 23: 851 856.
87. Deepak, R. N.,, B. Crawley,, and E. Phang. 2008. Burkholderia pseudomallei identification: a comparison between the API 20NE and VITEK2GN systems. Trans. R. Soc. Trop. Med. Hyg. 102( Suppl. 1): S42 S44.
88. Demko, C. A.,, R. C. Stern,, and C. F. Doershuk. 1998. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr. Pulmonol. 25: 304 308.
89. Denton, M.,, M. J. Hall,, N. J. Todd,, K. G. Kerr,, and J. M. Littlewood. 2000. Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium. Clin. Microbiol. Infect. 6: 397 398.
90. Denton, M.,, and K. G. Kerr. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11: 57 80.
91. Denton, M.,, N. J. Todd,, K. G. Kerr,, P. M. Hawkey,, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36: 1953 1958.
92. Desakorn, V.,, M. D. Smith,, V. Wuthiekanun,, D. A. Dance,, H. Aucken,, P. Suntharasamai,, A. Rajchanuwong,, and N. J. White. 1994. Detection of Pseudomonas pseudomallei antigen in urine for the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 51: 627 633.
93. De Soyza, A.,, A. McDowell,, L. Archer,, J. H. Dark,, S. J. Elborn,, E. Mahenthiralingam,, K. Gould,, and P. A. Corris. 2001. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358: 1780 1781.
94. Drancourt, M.,, C. Bollet,, and D. Raoult. 1997. Stenotrophomonas africana sp. nov., an opportunistic human pathogen in Africa. Int. J. Syst. Bacteriol. 47: 160 163.
95. Ender, P. T.,, D. P. Dooley,, and R. H. Moore. 1996. Vascular catheter-related Comamonas acidovorans bacteremia managed with preservation of the catheter. Pediatr. Infect. Dis. J. 15: 918 920.
96. Fernandez, C.,, I. Wilhelmi,, E. Andradas,, C. Gaspar,, J. Gomez,, J. Romero,, J. A. Mariano,, O. Corral,, M. Rubio,, J. Elviro,, and J. Fereres. 1996. Nosocomial outbreak of Burkholderia pickettii infection due to a manufactured intravenous product used in three hospitals. Clin. Infect. Dis. 22: 1092 1095.
97. Feterl, M.,, B. Govan,, C. Engler,, R. Norton,, and N. Ketheesan. 2006. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model. Int. J. Antimicrob. Agents 28: 460 464.
98. Fiore, A.,, S. Laevens,, A. Bevivino,, C. Dalmastri,, S. Tabacchioni,, P. Vandamme,, and L. Chiarini. 2001. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy. Environ. Microbiol. 3: 137 143.
99. Fujita, J.,, I. Yamadori,, G. Xu,, S. Hojo,, K. Negayama,, H. Miyawaki,, Y. Yamaji,, and J. Takahara. 1996. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir. Med. 90: 35 38.
100. Gardan, L.,, D. E. Stead,, C. Dauga,, and M. Gillis. 2003. Acidovorax valerianellae sp. nov., a novel pathogen of lamb’s lettuce [ Valerianella locusta (L.) Laterr.]. Int. J. Syst. Evol. Microbiol. 53: 795 800.
101. Garrison, M. W.,, D. E. Anderson,, D. M. Campbell,, K. C. Carroll,, C. L. Malone,, J. D. Anderson,, R. J. Hollis,, and M. A. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40: 2859 2864.
102. Gee, J. E.,, M. B. Glass,, R. T. Novak,, D. Gal,, M. J. Mayo,, A. G. Steigerwalt,, P. P. Wilkins,, and B. J. Currie. 2008. Recovery of a Burkholderia thailandensis-like isolate from an Australian water source. BMC Microbiol. 8: 54.
103. Gibney, K. B.,, A. C. Cheng,, and B. J. Currie. 2008. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin. Infect. Dis. 47: 603 609.
104. Gilad, J.,, A. Borer,, N. Peled,, K. Riesenberg,, S. Tager,, A. Appelbaum,, and F. Schlaeffer. 2000. Hospital-acquired Brevundimonas vesicularis septicaemia following open-heart surgery: case report and literature review. Scand. J. Infect. Dis. 32: 90 91.
105. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4: 35 51.
106. Gilligan, P. H.,, P. A. Gage,, L. M. Bradshaw,, D. V. Schidlow,, and B. T. DeCicco. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 22: 5 8.
107. Giordano, A.,, A. Magni,, M. Trancassini,, P. Varesi,, R. Turner,, and C. Mancini. 2006. Identification of respiratory isolates of Stenotrophomonas maltophilia by commercial biochemical systems and species-specific PCR. J. Microbiol. Methods 64: 135 138.
108. Glass, M. B.,, and T. Popovic. 2005. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J. Clin. Microbiol. 43: 479 483.
109. Godoy, D.,, G. Randle,, A. J. Simpson,, D. M. Aanensen,, T. L. Pitt,, R. Kinoshita,, and B. G. Spratt. 2003. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J. Clin. Microbiol. 41: 2068 2079.
110. Goris, J.,, P. De Vos,, T. Coenye,, B. Hoste,, D. Janssens,, H. Brim,, L. Diels,, M. Mergeay,, K. Kersters,, and P. Vandamme. 2001. Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. Int. J. Syst. Evol. Microbiol. 51: 1773 1782.
111. Goss, C. H.,, K. Otto,, M. L. Aitken,, and G. D. Rubenfeld. 2002. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 166: 356 361.
112. Govan, J. R.,, J. E. Hughes,, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45: 395 407.
113. Graff, G. R.,, and J. L. Burns. 2002. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Chest 121: 1754 1760.
114. Graves, M.,, T. Robin,, A. M. Chipman,, J. Wong,, S. Khashe,, and J. M. Janda. 1997. Four additional cases of Burkholderia gladioli infection with microbiological correlates and review. Clin. Infect. Dis. 25: 838 842.
115. Haase, A.,, M. Brennan,, S. Barrett,, Y. Wood,, S. Huffam,, D. O’Brien,, and B. Currie. 1998. Evaluation of PCR for diagnosis of melioidosis. J. Clin. Microbiol. 36: 1039 1041.
116. Hagedorn, C.,, W. D. Gould,, T. R. Bardinelli,, and D. R. Gustavson. 1987. A selective medium for enumeration and recovery of Pseudomonas cepacia biotypes from soil. Appl. Environ. Microbiol. 53: 2265 2268.
117. Han, X. Y.,, and R. A. Andrade. 2005. Brevundimonas diminuta infections and its resistance to fluoroquinolones. J. Antimicrob. Chemother. 55: 853 859.
118. Hancock, R. E. 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin. Infect. Dis. 27( Suppl. 1): S93 S99.
119. Hanes, S. D.,, K. Demirkan,, E. Tolley,, B. A. Boucher,, M. A. Croce,, G. C. Wood,, and T. C. Fabian. 2002. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin. Infect. Dis. 35: 228 235.
120. Heine, H. S.,, M. J. England,, D. M. Waag,, and W. R. Byrne. 2001. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob. Agents Chemother. 45: 2119 2121.
121. Henry, D.,, M. Campbell,, C. McGimpsey,, A. Clarke,, L. Louden,, J. L. Burns,, M. H. Roe,, P. Vandamme,, and D. Speert. 1999. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 37: 1004 1007.
122. Henry, D. A.,, M. E. Campbell,, J. J. LiPuma,, and D. P. Speert. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J. Clin. Microbiol. 35: 614 619.
123. Henry, D. A.,, E. Mahenthiralingam,, P. Vandamme,, T. Coenye,, and D. P. Speert. 2001. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 39: 1073 1078.
124. Heylen, K.,, B. Vanparys,, F. Peirsegaele,, L. Lebbe,, and P. De Vos. 2007. Stenotrophomonas terrae sp. nov. and Stenotrophomonas humi sp. nov., two nitrate-reducing bacteria isolated from soil. Int. J. Syst. Evol. Microbiol. 57: 2056 2061.
125. Hoban, D. J.,, S. K. Bouchillon,, J. L. Johnson,, G. G. Zhanel,, D. L. Butler,, L. A. Miller,, J. A. Poupard, et al. 2001. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Diagn. Microbiol. Infect. Dis. 40: 51 57.
126. Holt, J.,, N. R. Krieg,, A. Sneath,, T. Staley,, and S. T. Williams. 1994. Bergey’s Manual of Determinative Bacteriology, 9th ed., vol. 1. The Williams and Wilkins Company, Philadelphia, PA.
127. Howard, K.,, and T. J. Inglis. 2003. Novel selective medium for isolation of Burkholderia pseudomallei. J. Clin. Microbiol. 41: 3312 3316.
128. Hugh, R.,, and E. Ryschenkow. 1961. Pseudomonas maltophilia, an Alcaligenes-like species. J. Gen. Microbiol. 26: 123 132.
129. Hutchinson, G. R.,, S. Parker,, J. A. Pryor,, F. Duncan- Skingle,, P. N. Hoffman,, M. E. Hodson,, M. E. Kaufmann,, and T. L. Pitt. 1996. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistinresistant, gram-negative bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 34: 584 587.
130. Inglis, T. J.,, M. Aravena-Roman,, S. Ching,, K. Croft,, V. Wuthiekanun,, and B. J. Mee. 2003. Cellular fatty acid profile distinguishes Burkholderia pseudomallei from avirulent Burkholderia thailandensis. J. Clin. Microbiol. 41: 4812 4814.
131. Inglis, T. J.,, D. Chiang,, G. S. Lee,, and L. Chor-Kiang. 1998. Potential misidentification of Burkholderia pseudomallei by API 20NE. Pathology 30: 62 64.
132. Inglis, T. J.,, A. Merritt,, G. Chidlow,, M. Aravena-Roman,, and G. Harnett. 2005. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 43: 2201 2206.
133. Inglis, T. J.,, L. O’Reilly,, N. Foster,, A. Clair,, and J. Sampson. 2002. Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei. J. Clin. Microbiol. 40: 3198 3203.
134. Isles, A.,, I. Maclusky,, M. Corey,, R. Gold,, C. Prober,, P. Fleming,, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104: 206 210.
135. Jenney, A. W.,, G. Lum,, D. A. Fisher,, and B. J. Currie. 2001. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents 17: 109 113.
136. Johnson, L. N.,, J. Y. Han,, S. M. Moskowitz,, J. L. Burns,, X. Qin,, and J. A. Englund. 2004. Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness. Pediatr. Infect. Dis. J. 23: 881 882.
137. Johnson, W. M.,, S. D. Tyler,, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32: 924 930.
138. Jones, A. M.,, T. N. Stanbridge,, B. J. Isalska,, M. E. Dodd,, and A. K. Webb. 2001. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J. Infect. 42: 69 71.
139. Jorgensen, I. M.,, H. K. Johansen,, B. Frederiksen,, T. Pressler,, A. Hansen,, P. Vandamme,, N. Hoiby,, and C. Koch. 2003. Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr. Pulmonol. 36: 439 446.
140. Kaestli, M.,, M. Mayo,, G. Harrington,, L. Ward,, F. Watt,, J. V. Hill,, A. C. Cheng,, and B. J. Currie. 2009. Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl. Trop. Dis. 3: e364.
141. Kanaphun, P.,, N. Thirawattanasuk,, Y. Suputtamongkol,, P. Naigowit,, D. A. Dance,, M. D. Smith,, and N. J. White. 1993. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J. Infect. Dis. 167: 230 233.
142. Kenny, D. J.,, P. Russell,, D. Rogers,, S. M. Eley,, and R. W. Titball. 1999. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob. Agents Chem. 43: 2773 2775.
143. Kerr, K. G.,, M. Denton,, N. Todd,, C. M. Corps,, P. Kumari,, and P. M. Hawkey. 1996. A new selective differential medium for isolation of Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 15: 607 610.
144. Kersters, K.,, W. Ludwig,, M. Vancanneyt,, P. De Vos,, M. Gillis,, and K. H. Schleifer. 1996. Recent changes in the classification of the pseudomonads: an overview. Syst. Appl. Microbiol. 19: 465 477.
145. Khan, S. U.,, S. M. Gordon,, P. C. Stillwell,, T. J. Kirby,, and A. C. Arroliga. 1996. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr. Infect. Dis. J. 15: 637 639.
146. Kiska, D. L.,, A. Kerr,, M. C. Jones,, J. A. Caracciolo,, B. Eskridge,, M. Jordan,, S. Miller,, D. Hughes,, N. King,, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34: 886 891.
147. Krzewinski, J. W.,, C. D. Nguyen,, J. M. Foster,, and J. L. Burns. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39: 3597 3602.
148. Kutty, P. K.,, B. Moody,, J. S. Gullion,, M. Zervos,, M. Ajluni,, R. Washburn,, R. Sanderson,, M. A. Kainer,, T. A. Powell,, C. F. Clarke,, R. J. Powell,, N. Pascoe,, A. Shams,, J. J. LiPuma,, B. Jensen,, J. Noble-Wang,, M. J. Arduino,, and L. C. McDonald. 2007. Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest 132: 1825 1831.
149. Ledson, M. J.,, M. J. Gallagher,, M. Jackson,, C. A. Hart,, and M. J. Walshaw. 2002. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57: 142 145.
150. Le Moal, G.,, M. Paccalin,, J. P. Breux,, F. Roblot,, P. Roblot,, and B. Becq-Giraudon. 2001. Central venous catheterrelated infection due to Comamonas testosteroni in a woman with breast cancer. Scand. J. Infect. Dis. 33: 627 628.
151. Lessie, T. G.,, W. Hendrickson,, B. D. Manning,, and R. Devereux. 1996. Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol. Lett. 144: 117 128.
152. Limmathurotsakul, D.,, W. Chaowagul,, W. Chierakul,, K. Stepniewska,, B. Maharjan,, V. Wuthiekanun,, N. J. White,, N. P. Day,, and S. J. Peacock. 2006. Risk factors for recurrent melioidosis in northeast Thailand. Clin. Infect. Dis. 43: 979 986.
153. Liou, T. G.,, F. R. Adler,, S. C. FitzSimmons,, B. C. Cahill,, J. R. Hibbs,, and B. C. Marshall. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol. 153: 345 352.
154. LiPuma, J. 2003. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 24: 681 692.
155. LiPuma, J. J. 2001. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl. Infect. Dis. 3: 149 160.
156. LiPuma, J. J. 1998. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr. Opin. Pulm. Med. 4: 337 341.
157. LiPuma, J. J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19: 473 486.
158. LiPuma, J. J.,, S. E. Dasen,, D. W. Nielson,, R. C. Stern,, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336: 1094 1096.
159. LiPuma, J. J.,, B. J. Dulaney,, J. D. McMenamin,, P. W. Whitby,, T. L. Stull,, T. Coenye,, and P. Vandamme. 1999. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 37: 3167 3170.
160. LiPuma, J. J.,, J. E. Mortensen,, S. E. Dasen,, T. D. Edlind,, D. V. Schidlow,, J. L. Burns,, and T. L. Stull. 1988. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J. Pediatr. 113: 859 862.
161. LiPuma, J. J.,, T. Spilker,, T. Coenye,, and C. F. Gonzalez. 2002. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359: 2002 2003.
162. Lowe, P.,, C. Engler,, and R. Norton. 2002. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 40: 4625 4627.
163. Lowe, P.,, H. Haswell,, and K. Lewis. 2006. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN Card for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 44: 854 856.
164. Lumbiganon, P.,, U. Tattawasatra,, P. Chetchotisakd,, S. Wongratanacheewin,, and B. Thinkhamrop. 2000. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. J. Med. Assoc. Thai. 83: 856 860.
165. Mahenthiralingam, E.,, J. Bischof,, S. K. Byrne,, C. Radomski,, J. E. Davies,, Y. Av-Gay,, and P. Vandamme. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38: 3165 3173.
166. Mahenthiralingam, E.,, M. E. Campbell,, D. A. Henry,, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34: 2914 2920.
167. Mahenthiralingam, E.,, and P. Drevinek,. 2007. Comparative genomics of Burkholderia species, p. 53 79. In T. Coenye, and P. Vandamme (ed.), Burkholderia: Molecular Microbiology and Genomics. Horizon Bioscience, Wymondham, United Kingdom.
168. Makkar, N. S.,, and L. E. Casida, Jr. 1987. Cupriavidus necator gen. nov., sp. nov.; a nonobligate bacterial predator of bacteria in soil. Int. J. Syst. Bacteriol. 37: 323 326.
169. McDowell, A.,, E. Mahenthiralingam,, J. E. Moore,, K. E. A. Dunbar,, A. K. Webb,, M. E. Dodd,, S. L. Martin,, B. C. Millar,, C. J. Scott,, M. Crowe,, and J. S. Elborn. 2001. PCRbased detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J. Clin. Microbiol. 39: 4247 4255.
170. McMenamin, J. D.,, T. M. Zaccone,, T. Coenye,, P. Vandamme,, and J. J. LiPuma. 2000. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117: 1661 1665.
171. Meumann, E. M.,, R. T. Novak,, D. Gal,, M. E. Kaestli,, M. Mayo,, J. P. Hanson,, E. Spencer,, M. B. Glass,, J. E. Gee,, P. P. Wilkins,, and B. J. Currie. 2006. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J. Clin. Microbiol. 44: 3028 3030.
172. Milatovic, D.,, F. J. Schmitz,, J. Verhoef,, and A. C. Fluit. 2003. Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob. Agents Chemother. 47: 400 404.
173. Moore, J. E.,, B. McIlhatton,, A. Shaw,, P. G. Murphy,, and J. S. Elborn. 2001. Occurrence of Burkholderia cepacia in foods and waters: clinical implications for patients with cystic fibrosis. J. Food Prot. 64: 1076 1078.
174. Moore, J. E.,, J. Xu,, B. C. Millar,, M. Crowe,, and J. S. Elborn. 2002. Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis. J. Microbiol. Methods 49: 183 191.
175. Moore, R. A.,, S. Reckseidler-Zenteno,, H. Kim,, W. Nierman,, Y. Yu,, A. Tuanyok,, J. Warawa,, D. DeShazer,, and D. E. Woods. 2004. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect. Immun. 72: 4172 4187.
176. Muder, R. R.,, A. P. Harris,, S. Muller,, M. Edmond,, J. W. Chow,, K. Papadakis,, M. W. Wagener,, G. P. Bodey,, and J. M. Steckelberg. 1996. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin. Infect. Dis. 22: 508 512.
177. Murray, S.,, J. Charbeneau,, B. C. Marshall,, and J. J. LiPuma. 2008. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 178: 363 371.
178. Ngauy, V.,, Y. Lemeshev,, L. Sadkowski,, and G. Crawford. 2005. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J. Clin. Microbiol. 43: 970 972.
179. Novak, R. T.,, M. B. Glass,, J. E. Gee,, D. Gal,, M. J. Mayo,, B. J. Currie,, and P. P. Wilkins. 2006. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J. Clin. Microbiol. 44: 85 90.
180. O’Brien, M.,, K. Freeman,, G. Lum,, A. C. Cheng,, S. P. Jacups,, and B. J. Currie. 2004. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J. Clin. Microbiol. 42: 2239 2240.
181. O’Carroll, M. R.,, T. J. Kidd,, C. Coulter,, H. V. Smith,, B. R. Rose,, C. Harbour,, and S. C. Bell. 2003. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax 58: 1087 1091.
182. Oie, S.,, and A. Kamiya. 1996. Microbial contamination of antiseptics and disinfectants. Am. J. Infect. Control 24: 389 395.
183. Otag, F.,, G. Ersoz,, M. Salcioglu,, C. Bal,, I. Schneider,, and A. Bauernfeind. 2005. Nosocomial bloodstream infections with Burkholderia stabilis. J. Hosp. Infect. 59: 46 52.
184. Otto, L. A.,, B. S. Deboo,, E. L. Capers,, and M. J. Pickett. 1978. Pseudomonas vesicularis from cervical specimens. J. Clin. Microbiol. 7: 341 345.
185. Palleroni, N. J., 1984. Genus I. Pseudomonas Migula 1984 237AL, p. 141 199. In J. Holt, and N. R. Krieg (ed.), Bergey’s Manual of Systematic Bacteriology, vol. 1. The Williams and Wilkins Company, Baltimore, MD.
186. Palleroni, N. J.,, and J. F. Bradbury. 1993. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int. J. Syst. Bacteriol. 43: 606 609.
187. Palleroni, N. J.,, R. Kunisawa,, R. Contopoulou, et al. 1973. Nucleid acid homologies in the genus Pseudomonas. Int. J. Syst. Bacteriol. 23: 333.
188. Parke, J. L.,, and D. Gurian-Sherman. 2001. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu. Rev. Phytopathol. 39: 225 258.
189. Parry, C. M.,, V. Wuthiekanun,, N. T. Hoa,, T. S. Diep,, L. T. Thao,, P. V. Loc,, B. A. Wills,, J. Wain,, T. T. Hien,, N. J. White,, and J. J. Farrar. 1999. Melioidosis in Southern Vietnam: clinical surveillance and environmental sampling. Clin. Infect. Dis. 29: 1323 1326.
190. Payne, G. W.,, P. Vandamme,, S. H. Morgan,, J. J. LiPuma,, T. Coenye,, A. J. Weightman,, T. H. Jones,, and E. Mahenthiralingam. 2005. Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl. Environ. Microbiol. 71: 3917 3927.
191. Peacock, S. J.,, G. Chieng,, A. C. Cheng,, D. A. Dance,, P. Amornchai,, G. Wongsuvan,, N. Teerawattanasook,, W. Chierakul,, N. P. Day,, and V. Wuthiekanun. 2005. Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J. Clin. Microbiol. 43: 5359 5361.
192. Peacock, S. J.,, H. P. Schweizer,, D. A. Dance,, T. L. Smith,, J. E. Gee,, V. Wuthiekanun,, D. DeShazer,, I. Steinmetz,, P. Tan,, and B. J. Currie. 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg. Infect. Dis. 14: e2.
193. Piliouras, P.,, G. C. Ulett,, C. Ashhurst-Smith,, R. G. Hirst,, and R. E. Norton. 2002. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Int. J. Antimicrob. Agents 19: 427 429.
194. Pitkin, D. H.,, W. Sheikh,, and H. L. Nadler. 1997. Comparative in vitro activity of meropenem versus other extended- spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers. Clin. Infect. Dis. 24( Suppl. 2): S238 S248.
195. Pitt, T. L.,, M. E. Kaufmann,, P. S. Patel,, L. C. Benge,, S. Gaskin,, and D. M. Livermore. 1996. Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44: 203 210.
196. Poole, K.,, and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1: 59 71.
197. Ramette, A.,, J. J. LiPuma,, and J. M. Tiedje. 2005. Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl. Environ. Microbiol. 71: 1193 1201.
198. Razvi, S.,, L. Quittell,, A. Sewall,, H. Quinton,, B. Marshall,, and L. Saiman. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995-2005. Chest 136: 1554 1560.
199. Reboli, A. C.,, R. Koshinski,, K. Arias,, K. Marks-Austin,, D. Stieritz,, and T. L. Stull. 1996. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect. Control Hosp. Epidemiol. 17: 741 743.
200. Reik, R.,, T. Spilker,, and J. J. LiPuma. 2005. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 43: 2926 2928.
201. Riley, P. S.,, and R. E. Weaver. 1975. Recognition of Pseudomonas pickettii in the clinical laboratory: biochemical characterization of 62 strains. J. Clin. Microbiol. 1: 61 64.
202. Ross, J. P.,, S. M. Holland,, V. J. Gill,, E. S. DeCarlo,, and J. I. Gallin. 1995. Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin. Infect. Dis. 21: 1291 1293.
203. Sajjan, U. S.,, L. Sun,, R. Goldstein,, and J. F. Forstner. 1995. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177: 1030 1038.
204. San Gabriel, P.,, J. Zhou,, S. Tabibi,, Y. Chen,, M. Trauzzi,, and L. Saiman. 2004. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 48: 168 171.
205. Sattler, C. A.,, E. O. Mason, Jr.,, and S. L. Kaplan. 2000. Nonrespiratory Stenotrophomonas maltophilia infection at a children’s hospital. Clin. Infect. Dis. 31: 1321 1330.
206. Segers, P.,, M. Vancanneyt,, B. Pot,, U. Torck,, B. Hoste,, D. Dewettinck,, E. Falsen,, K. Kersters,, and P. De Vos. 1994. Classification of Pseudomonas diminuta Leifson and Hugh 1954 and Pseudomonas vesicularis Busing, Doll, and Freytag 1953 in Brevundimonas gen. nov. as Brevundimonas diminuta comb. nov. and Brevundimonas vesicularis comb. nov., respectively. Int. J. Syst. Bacteriol. 44: 499 510.
207. Segonds, C.,, T. Heulin,, N. Marty,, and G. Chabanon. 1999. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J. Clin. Microbiol. 37: 2201 2208.
208. Segonds, C.,, S. Paute,, and G. Chabanon. 2003. Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis. J. Clin. Microbiol. 41: 3415 3418.
209. Shelly, D. B.,, T. Spilker,, E. J. Gracely,, T. Coenye,, P. Vandamme,, and J. J. LiPuma. 2000. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J. Clin. Microbiol. 38: 3112 3115.
210. Smith, M. D.,, B. J. Angus,, V. Wuthiekanun,, and N. J. White. 1997. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect. Immun. 65: 4319 4321.
211. Smith, M. D.,, V. Wuthiekanun,, A. L. Walsh,, N. Teerawattanasook,, V. Desakorn,, Y. Suputtamongkol,, T. L. Pitt,, and N. J. White. 1995. Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J. Clin. Pathol. 48: 174 176.
212. Sneath, P. H. A. 1992. International Code of Nomenclature of Bacteria. 1990 Revision. American Society for Microbiology, Washington, DC.
213. Speert, D. P.,, D. Henry,, P. Vandamme,, M. Corey,, and E. Mahenthiralingam. 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis. 8: 181 187.
214. Spilker, T.,, A. Baldwin,, A. Bumford,, C. G. Dowson,, E. Mahenthiralingam,, and J. J. LiPuma. 2009. Expanded multilocus sequence typing for Burkholderia species. J. Clin. Microbiol. 47: 2607 2610.
215. Stead, D. E. 1992. Grouping of plant-pathogenic and some other Pseudomonas spp. by using cellular fatty acid profiles. Int. J. Syst. Evol. Microbiol. 42: 281 285.
216. Stryjewski, M. E.,, J. J. LiPuma,, R. H. Messier, Jr.,, L. B. Reller,, and B. D. Alexander. 2003. Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. J. Clin. Microbiol. 41: 2255 2257.
217. Swings, J.,, P. De Vos,, M. Van den Mooter,, and J. De Ley. 1983. Transfer of Pseudomonas maltophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. Int. J. Syst. Bacteriol. 33: 409 413.
218. Talmaciu, I.,, L. Varlotta,, J. Mortensen,, and D. V. Schidlow. 2000. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr. Pulmonol. 30: 10 15.
219. Thamlikitkul, V.,, and S. Trakulsomboon. 2006. In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis. Antimicrob. Agents Chemother. 50: 1555 1557.
220. Thibault, F. M.,, E. Valade,, and D. R. Vidal. 2004. Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes. J. Clin. Microbiol. 42: 5871 5874.
221. Thomassen, M. J.,, C. A. Demko,, J. D. Klinger,, and R. C. Stern. 1985. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am. Rev. Respir. Dis. 131: 791 796.
222. Tiangpitayakorn, C. 1997. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am. J. Trop. Med. Hyg. 57: 96 99.
223. Tomaso, H.,, T. L. Pitt,, O. Landt,, S. Al Dahouk,, H. C. Scholz,, E. C. Reisinger,, L. D. Sprague,, I. Rathmann,, and H. Neubauer. 2005. Rapid presumptive identification of Burkholderia pseudomallei with real-time PCR assays using fluorescent hybridization probes. Mol. Cell. Probes 19: 9 20.
224. Vancouvenberghe, C. 1994. Analysis of epidemic and endemic isolates of Xanthomonas maltophilia by contourclamped homogeneous electric field gel electrophoresis. Infect. Control Hosp. Epidemiol. 15: 691 696.
225. Vandamme, P.,, and T. Coenye. 2004. Taxonomy of the genus Cupriavidus: a tale of lost and found. Int. J. Syst. Evol. Microbiol. 54: 2285 2289.
226. Vandamme, P.,, J. Goris,, T. Coenye,, B. Hoste,, D. Janssens,, K. Kersters,, P. De Vos,, and E. Falsen. 1999. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int. J. Syst. Bacteriol. 49: 663 669.